Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabidiol Drugs Clinical Trial Outcomes and Adverse Effects
Christopher S. Pauli, Matthieu Conroy, Brian D. Vanden Heuvel, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Accuracy of EEG Biomarkers in the Detection of Clinical Outcome in Disorders of Consciousness after Severe Acquired Brain Injury: Preliminary Results of a Pilot Study Using a Machine Learning Approach
Francesco Di Gregorio, Fabio La Porta, Valeria Petrone, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1897-1897
Open Access | Times Cited: 73
Medical cannabis use in the Australian community following introduction of legal access: the 2018–2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18)
Nicholas Lintzeris, Llewellyn Mills, Anastasia Suraev, et al.
Harm Reduction Journal (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 106
Content versus Label Claims in Cannabidiol (CBD)-Containing Products Obtained from Commercial Outlets in the State of Mississippi
Bill J. Gurley, Timothy F. Murphy, Waseem Gul, et al.
Journal of Dietary Supplements (2020) Vol. 17, Iss. 5, pp. 599-607
Closed Access | Times Cited: 79
Effects of short-term environmental stresses on the onset of cannabinoid production in young immature flowers of industrial hemp (Cannabis sativa L.)
Sang‐Hyuck Park, Christopher S. Pauli, Eric L. Gostin, et al.
Journal of Cannabis Research (2022) Vol. 4, Iss. 1
Open Access | Times Cited: 45
Cannabis Contaminants Limit Pharmacological Use of Cannabidiol
Zackary T. Montoya, Matthieu Conroy, Brian D. Vanden Heuvel, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 54
Real World Evidence in Medical Cannabis Research
R. Banerjee, Simon Erridge, Oliver Salazar, et al.
Therapeutic Innovation & Regulatory Science (2021) Vol. 56, Iss. 1, pp. 8-14
Open Access | Times Cited: 49
Chemical Profiling and Characterization of Different Cultivars of Cannabis sativa L. Inflorescences by SPME-GC-MS and UPLC-MS
Vittoria Cicaloni, Laura Salvini, Sara Vitalini, et al.
Separations (2022) Vol. 9, Iss. 4, pp. 90-90
Open Access | Times Cited: 30
Anti-Microbial Activity of Phytocannabinoids and Endocannabinoids in the Light of Their Physiological and Pathophysiological Roles
Ronit Vogt Sionov, Doron Steinberg
Biomedicines (2022) Vol. 10, Iss. 3, pp. 631-631
Open Access | Times Cited: 28
Cannabidiol sensitizes TRPV2 channels to activation by 2-APB
Aaron Gochman, Xiao-Feng Tan, Chanhyung Bae, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 17
The effects of simultaneous alcohol and cannabis use on subjective drug effects: A narrative review across methodologies
Margaret F. Bedillion, Eric D. Claus, Stephanie Wemm, et al.
Alcohol Clinical and Experimental Research (2024) Vol. 48, Iss. 6, pp. 988-999
Open Access | Times Cited: 7
Oral formulations for highly lipophilic drugs: Impact of surface decoration on the efficacy of self-emulsifying drug delivery systems
Matthias Sandmeier, Julia Hoeng, Sanne Jensen, et al.
Journal of Colloid and Interface Science (2024) Vol. 677, pp. 1108-1119
Open Access | Times Cited: 6
Current and Potential Use of Biologically Active Compounds Derived from Cannabis sativa L. in the Treatment of Selected Diseases
Bożena Bukowska
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12738-12738
Open Access | Times Cited: 6
Fish Oil, Cannabidiol and the Gut Microbiota: An Investigation in a Murine Model of Colitis
Cristoforo Silvestri, Ester Pagano, Sébastien Lacroix, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 49
Sex differences in the neurochemistry of frontal cortex: Impact of early life stress
Christina J. Perry, Erin J. Campbell, Katherine Drummond, et al.
Journal of Neurochemistry (2020) Vol. 157, Iss. 4, pp. 963-981
Open Access | Times Cited: 45
Cannabis and cannabidiol (CBD) for the treatment of fibromyalgia
Amnon A. Berger, Joseph Keefe, Ariel Winnick, et al.
Best Practice & Research Clinical Anaesthesiology (2020) Vol. 34, Iss. 3, pp. 617-631
Closed Access | Times Cited: 43
Natural Salicylates and Their Roles in Human Health
Fatema Yeasmin, Hyong Woo Choi
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 23, pp. 9049-9049
Open Access | Times Cited: 35
Cancer Initiation, Progression and Resistance: Are Phytocannabinoids from Cannabis sativa L. Promising Compounds?
Ersilia Nigro, Marialuisa Formato, Giuseppina Crescente, et al.
Molecules (2021) Vol. 26, Iss. 9, pp. 2668-2668
Open Access | Times Cited: 27
Thermal decarboxylation of acidic cannabinoids in Cannabis species: identification of transformed cannabinoids by UHPLC-Q/TOF–MS
Chaeyoung Seo, Minsun Jeong, Sangin Lee, et al.
Journal of Analytical Science & Technology (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 21
<b><i>Cannabis sativa</i></b> and Cannabidiol: A Therapeutic Strategy for the Treatment of Neurodegenerative Diseases?
Milena de Barros Viana, Pedro Everson Alexandre de Aquino, Débora Estadella, et al.
Medical Cannabis and Cannabinoids (2022) Vol. 5, Iss. 1, pp. 207-219
Open Access | Times Cited: 20
Medicinal cannabis for psychiatry-related conditions: an overview of current Australian prescribing
Elizabeth A. Cairns, Melissa J. Benson, Miguel A. Bedoya‐Pérez, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 12
Oral Cannabidiol Treatment Is Associated with an Anti-Inflammatory Gene Expression Signature in Myeloid Cells of People Living with HIV
Simone Marini, Amanda K. Huber, Melanie N. Cash, et al.
Cannabis and Cannabinoid Research (2024) Vol. 9, Iss. 4, pp. 1028-1037
Closed Access | Times Cited: 4
Chemistry and pharmacological aspects of furanoid cannabinoids and related compounds: Is furanoid cannabinoids open a new dimension towards the non-psychoactive cannabinoids?
Radhika Anand, Ritu Painuli, Vijay Kumar, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116164-116164
Closed Access | Times Cited: 4
CBD and the 5-HT1A receptor: A medicinal and pharmacological review
Claire Alexander, Jiyoon Jeon, Kyle Nickerson, et al.
Biochemical Pharmacology (2025) Vol. 233, pp. 116742-116742
Closed Access
Recent Advancement of NMR in Drug Discovery Systems
Devesh Chandra, Nitisha Sendri
Advances in chemical and materials engineering book series (2025), pp. 151-170
Closed Access
Recent advances in cannabidiol (CBD) extraction: a review of potential eco-friendly solvents and advanced technologies
Saranya Selvaraj, Nazeefa Nawfer, K.V. Surangi Dharmawansa, et al.
Green Analytical Chemistry (2025), pp. 100270-100270
Open Access
Page 1 - Next Page

Scroll to top